High-Intensity Focused Ultrasound (HIFU) Market : Insights &

April 15, 2025

High-Intensity Focused Ultrasound (HIFU) Market – Global Forecast 2025–2033, Size, Share, Growth, Trends, Impact of Inflation, and Company Analysis

Market Overview

The global High-Intensity Focused Ultrasound (HIFU) market is poised for significant expansion, expected to reach US$ 242.58 Million by 2033, up from US$ 124.44 Million in 2024, growing at a CAGR of 7.70% from 2025 to 2033. This growth is driven by an increasing preference for non-invasive therapeutic options, rapid advancements in ultrasound technology, and growing global incidences of chronic conditions such as cancer and uterine fibroids. As healthcare systems worldwide transition towards minimally invasive therapies, HIFU is emerging as a revolutionary treatment alternative with wide clinical applications and promising outcomes.

Market Dynamics

Drivers of Market Growth

Advancements in Ultrasound Technology

Recent technological breakthroughs have significantly transformed the landscape of high-intensity focused ultrasound therapy. Enhanced imaging precision, real-time monitoring capabilities, and improved treatment safety have made HIFU a viable option for treating various conditions with minimal collateral damage. Portable, cost-effective, and user-friendly systems like GE HealthCare’s Versana Premier (launched in October 2024) are democratizing access to HIFU, even in resource-constrained settings.

Surging Demand for Non-Invasive Procedures

HIFU offers a scar-free, incision-less therapeutic option, which appeals to patients who seek quick recovery times and fewer postoperative complications. Its expanding applications in treating tumors, uterine fibroids, neurological disorders, and aesthetic conditions make it an attractive alternative to traditional surgery. Collaborations, like that of GE HealthCare and Novo Nordisk (October 2023), highlight ongoing innovation to explore HIFU’s potential in metabolic disorders such as obesity and type 2 diabetes.

Rising Global Burden of Chronic Diseases

The incidence of chronic diseases—especially cancers—is accelerating globally. According to 2022 data, there were over 20 million new cancer cases and 9.7 million cancer-related deaths worldwide. The demand for non-invasive, organ-preserving, and patient-friendly treatment options like HIFU is growing correspondingly. HIFU’s ability to deliver focused ablation of tumors with limited side effects contributes to its increasing adoption in oncology practices.

Market Challenges

High Capital Costs and Limited Accessibility

Despite its clinical advantages, the high cost associated with HIFU devices and the need for technologically advanced infrastructure restrict its accessibility, especially in low-to-middle income countries. Hospitals with limited funding often cannot afford the acquisition and maintenance of these systems, impeding broader adoption.

Shortage of Skilled Healthcare Professionals

HIFU procedures demand high precision and expertise in ultrasound imaging and real-time adjustments. A global shortage of trained specialists, particularly in emerging markets, hampers effective treatment outcomes. This gap necessitates large-scale training programs and educational initiatives to build a qualified workforce capable of leveraging this technology to its full potential.

Related Report

Regional Analysis

United States

The U.S. is a frontrunner in the adoption of HIFU therapy, owing to a robust healthcare infrastructure, increasing cancer prevalence, and ongoing clinical trials. In 2022, the country recorded 230,125 prostate cancer cases and 33,746 related deaths. Government-funded research, like the National Cancer Institute’s Phase II trial on prostate cancer radiation therapy (scheduled to conclude in 2028), underlines continued innovation and expansion of HIFU applications.

Germany

Germany’s healthcare system is distinguished by its focus on technological integration and non-invasive treatment approaches. The country is increasingly incorporating HIFU in routine medical practice, supported by public investments and collaborations. For instance, Exo’s partnership with Sana Kliniken AG (June 2023) exemplifies efforts to scale real-time decision-making using AI-driven portable ultrasound platforms.

China

China is experiencing rapid growth in HIFU adoption due to an escalating prevalence of cancer and a healthcare system striving for modernization. With investments in advanced therapies, major urban centers such as Beijing and Shanghai are integrating HIFU into oncology and chronic care treatment. GE Healthcare’s joint venture with a Chinese state-owned pharmaceutical company in February 2023 emphasizes the country’s strategic move toward improving accessibility to high-quality imaging solutions.

Brazil

Brazil is an emerging HIFU market in Latin America, supported by a growing medical tourism sector and healthcare reforms. The launch of an innovation lab by Philips Foundation and SAS Brasil in July 2024 reflects ongoing efforts to boost digital health education and expand access to quality healthcare in underserved areas, further propelling the use of advanced therapies like HIFU.

Saudi Arabia

The Kingdom of Saudi Arabia is aggressively investing in cutting-edge medical technologies to enhance its healthcare services. The adoption of HIFU is gaining momentum, particularly in treating cancers and uterine fibroids, supported by initiatives like the Global Health Exhibition (October 2023), where Philips showcased next-generation healthcare innovations.

Market Segmentation

By Imaging Technology

Ultrasound HIFU Therapy
MRI HIFU Therapy

By Application

Prostate Cancer
Uterine Fibroids
Neurological Disorders
Aesthetics
Others

By End User

Hospitals
Diagnostic Centers
Research Centers
Others

Geographic Coverage

Detailed analysis from 26 countries across 5 key regions:

North America

United States
Canada

Europe

Germany, France, UK, Italy, Spain, Netherlands, Belgium, Turkey

Asia-Pacific

China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, New Zealand

Latin America

Brazil, Mexico, Argentina

Middle East & Africa

Saudi Arabia, UAE, South Africa

Competitive Landscape

Key Players Covered

Koninklijke Philips N.V.
Johnson & Johnson
Hitachi Ltd.
General Electric
Medtronic Plc.
Stryker Corporation
EDAP TMS S.A.
Theraclion

Company Analysis Includes

Company Overview
Recent Developments
Revenue Analysis

Recent developments such as GE’s collaboration with Novo Nordisk and Exo’s AI-powered ultrasound expansion reflect strategic initiatives to broaden HIFU’s clinical footprint and enhance global market penetration.

Report Scope & Customization

Report Details